The efficacy of 2-nitrovinylfuran derivatives againstLeishmania in vitro and in vivo
AUTOR(ES)
Sifontes-Rodríguez, Sergio, Monzote-Fidalgo, Lianet, Castañedo-Cancio, Nilo, Montalvo-Álvarez, Ana Margarita, López-Hernández, Yamilé, Diogo, Niurka Mollineda, Infante-Bourzac, Juan Francisco, Pérez-Martín, Oliver, Meneses-Marcel, Alfredo, García-Trevijano, José Antonio Escario, Cabrera-Pérez, Miguel Ángel
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
24/03/2015
RESUMO
Despite recent advances in the treatment of some forms of leishmaniasis, the available drugs are still far from ideal due to inefficacy, parasite resistance, toxicity and cost. The wide-spectrum antimicrobial activity of 2-nitrovinylfuran compounds has been described, as has their activity against Trichomonas vaginalis and other protozoa. Thus, the aim of this study was to test the antileishmanial activities of six 2-nitrovinylfurans in vitro and in a murine model of leishmaniasis. Minimum parasiticide concentration (MPC) and 50% inhibitory concentration (IC50) values for these compounds against the promastigotes of Leishmania amazonensis, Leishmania infantum and Leishmania braziliensis were determined, as were the efficacies of two selected compounds in an experimental model of cutaneous leishmaniasis (CL) caused by L. amazonensis in BALB/c mice. All of the compounds were active against the promastigotes of the three Leishmania species tested. IC50 and MPC values were in the ranges of 0.8-4.7 µM and 1.7-32 µM, respectively. The compounds 2-bromo-5-(2-bromo-2-nitrovinyl)-furan (furvina) and 2-bromo-5-(2-methyl-2-nitrovinyl)-furan (UC245) also reduced lesion growth in vivo at a magnitude comparable to or higher than that achieved by amphotericin B treatment. The results demonstrate the potential of this class of compounds as antileishmanial agents and support the clinical testing of Dermofural(r) (a furvina-containing antifungal ointment) for the treatment of CL.
Documentos Relacionados
- In vitro evaluation of new terpenoid derivatives against Leishmania infantum and Leishmania braziliensis
- In Vitro and In Vivo Efficacy of the Triazole TAK-187 against Cryptococcus neoformans
- In Vitro and In Vivo Activities of Aminoadamantane and Aminoalkylcyclohexane Derivatives against Trypanosoma brucei
- Activity of the antiarrhythmic drug amiodarone against Leishmania (L.) infantum: an in vitro and in vivo approach
- In Vitro and in Vivo Assays of 3,5-Disubstituted-Tetrahydro-2H-1,3,5-Thiadiazin-2-Thione Derivatives against Trypanosoma cruzi